etidronate has been researched along with Apoplexy in 7 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Before the drugs were started, patients later initiating alendronate or raloxifene had fewer strokes than the controls." | 3.77 | Stroke in relation to use of raloxifene and other drugs against osteoporosis. ( Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P, 2011) |
| "After patients with osteoporosis are identified, the challenge is to treat them appropriately." | 2.47 | Treatments for osteoporosis in people with a disability. ( Smith, EM, 2011) |
| "Neurological diseases, including Alzheimer's disease, stroke, and Parkinson's disease have been reported to increase the risk for fractures." | 2.44 | Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. ( Iwamoto, J; Matsumoto, H; Takeda, T, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, Y | 3 |
| Iwamoto, J | 3 |
| Honda, Y | 1 |
| Vestergaard, P | 1 |
| Schwartz, K | 1 |
| Pinholt, EM | 1 |
| Rejnmark, L | 1 |
| Mosekilde, L | 1 |
| Smith, EM | 1 |
| Kanoko, T | 1 |
| Satoh, K | 1 |
| Poole, KE | 1 |
| Warburton, EA | 1 |
| Reeve, J | 1 |
| Matsumoto, H | 1 |
| Takeda, T | 1 |
| Asoh, T | 1 |
| Kaji, M | 1 |
| Oizumi, K | 1 |
2 reviews available for etidronate and Apoplexy
| Article | Year |
|---|---|
Treatments for osteoporosis in people with a disability.
Topics: Bone Density; Bone Density Conservation Agents; Diphosphonates; Disabled Persons; Etidronic Acid; Hu | 2011 |
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Bone Density Conservation Agents; Conf | 2008 |
3 trials available for etidronate and Apoplexy
| Article | Year |
|---|---|
RETRACTED: Beneficial effect of etidronate therapy in chronically hospitalized, disabled patients with stroke.
Topics: Aged; Body Mass Index; Bone Density; Bone Density Conservation Agents; Calcium; Chronic Disease; Dis | 2010 |
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Topics: Accidental Falls; Aged; Bone Density; Bone Density Conservation Agents; Calcium; Double-Blind Method | 2005 |
Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
Topics: Absorptiometry, Photon; Aged; Amino Acids; Bone Density; Bone Diseases, Metabolic; Calcium; Collagen | 2000 |
2 other studies available for etidronate and Apoplexy
| Article | Year |
|---|---|
Stroke in relation to use of raloxifene and other drugs against osteoporosis.
Topics: Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control Studies; Denmar | 2011 |
Risedronate therapy for prevention of hip fracture after stroke in elderly women.
Topics: Accidental Falls; Aged; Bone Density Conservation Agents; Causality; Clinical Trials as Topic; Etidr | 2005 |